Abstract
The present study focuses on the development of dry powders for inhalation as adjuvant chemotherapy in lung cancer treatment. Cisplatin was chosen as a potential candidate for a local treatment as it remains the main platinum component used in conventional chemotherapies, despite its high and cumulative systemic toxicities. Bulk cisplatin was reduced to submicron sizes using high-pressure homogenization, mixed with a solubilized lipid and/or PEGylated component and then spray-dried to produce controlled-release dry powder formulations. The obtained formulations were characterized for their physicochemical properties (particle size and morphology), aerodynamic performance and release profiles. Cisplatin content and integrity were assessed by electrothermal atomic absorption spectrometry and 195Pt nuclear magnetic resonance spectroscopy. DPI formulations with cisplatin contents ranging from 48.5 to 101.0% w/w exhibited high fine particle fractions ranging from 37.3% to 51.5% of the nominal dose. Formulations containing cisplatin microcrystals dispersed in solid lipid microparticles based on acceptable triglycerides for inhalation and PEGylated excipients showed a controlled-release for more than 24 h and a limited burst effect. These new formulations could provide an interesting approach to increasing and prolonging drug exposure in the lung while minimizing systemic toxicities.
Original language | English |
---|---|
Pages (from-to) | 209-220 |
Number of pages | 12 |
Journal | International Journal of Pharmaceutics |
Volume | 515 |
Issue number | 1-2 |
DOIs | |
Publication status | Published - 30 Dec 2016 |
Keywords
- Cisplatin
- Controlled-release
- Dry powder inhaler
- Lung cancer chemotherapy
- Pulmonary delivery
- Solid lipid microparticles
Fingerprint
Dive into the research topics of 'Development of controlled-release cisplatin dry powders for inhalation against lung cancers'. Together they form a unique fingerprint.Equipment
-
Physical Chemistry and characterization(PC2)
Johan Wouters (Manager) & Carmela Aprile (Manager)
Technological Platform Physical Chemistry and characterizationFacility/equipment: Technological Platform